Commemorative Series No. 2 · The Drug Money
OUTSPENTNo. 22/54
Saxby
Chambliss
U.S. Senate · R-GA
Taken from pharma & insurers
$48,535
H.R.1 · Medicare drug-price ban · 2003tap to flip ⤺
WHO THEY WORK FORNo. 22/54
Pharma & Health$25,285
Insurers & HMOs$23,250
Banned Medicare from negotiating drug prices for 19 years. Once it could (2024), prices fell 38–79%. · 108-1-459OUTSPENT
Card 22 of 54 · tap the card to see who they work for
Beyond the check
The check is only the part you can see.
They took
$48,535
The industry spent on the bill
$116M
on drug-industry lobbying in 2003, about ten lobbyists for every senator
Then, after office
Joined the board of the financial-services firm Primerica.
Source: SEC, 2017
The industry figure is lobbying spent on the bill, not a payment to this senator. Source: Public Citizen (2004); Center for Public Integrity. Everything here is documented public record; nothing alleges an illegal act.
Don't recognize a logo? Here's the key.
Pharma & Health$25,285
Johnson & Johnson$20,800
PhRMA$2,000
Pfizer$1,610
Bristol Myers Squibb$625
Merck$250
Insurers & HMOs$23,250
Aetna$23,000
Anthem/Elevance$250